wps.20438

Lambda Light Chain Antibody (Mc24-IC6) Summary

    Immunogen
    Purified human IgG.
    Localization
    Cytoplasmic
    Specificity
    Recognises human lambda light chains, and shows no cross- reactivity to kappa light chains or to immunoglobulin heavy chains.
    Isotype
    IgG1
    Clonality
    Monoclonal
    Host
    Mouse
    Gene
    IGLC2
    Purity
    Protein A purified
    Innovators Reward
    Test in a species/application not listed above to receive a full credit towards a future purchase.

    Learn about the Innovators Reward

Applications/Dilutions

    Dilutions
        ELISA 1:100-1:2000
        Flow Cytometry 1:10-1:20

Packaging, Storage & Formulations

    Storage
    Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
    Buffer
    PBS
    Preservative
    0.09% Sodium Azide
    Concentration
    0.5 mg/ml
    Purity
    Protein A purified

Alternate Names for Lambda Light Chain Antibody (Mc24-IC6)

      IGLC
      immunoglobulin lambda constant group

Background

All five immunoglobulin classes share the same basic four polypeptide chain structure of two heavy-chains and two light chains. There are five heavy chain types, and two light-chain types (Kappa and Lambda) both having a molecular weight of 22.5kDa. Any heavy-chain type can associate with either light-chain type, but on any immunoglobulin molecule both light-chains are of the same type. Kappa and Lambda consist of a variable region and a constant region and can easily be differentiated by the antigenic properties of the constant region. The ratio of Kappa to Lambda is 70:30, the vast majority of which is bound to heavy-chain in immunoglobulin. In normal individuals low levels of free light-chain arepresent in serum (kappa, 1.6-15.2 mg/L; Lambda, 0.4-4.2mg/L), with the occurrence of multiple myeloma or other B-cell malignancies these levels can be greatly elevated and can be found at high levels in the urine (Bence-Jones proteins).

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

APTO-253

Related Post